Stress ulcer prophylaxis [2]

Critical Care Medicine

Volumn 32, Issue 7, 2004, Pages 1626-

  DePriest, Jack L ^a  

^a MEMORIAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTACID AGENT; HISTAMINE H2 RECEPTOR ANTAGONIST; RANITIDINE; SUCRALFATE;

ARTIFICIAL VENTILATION; BLEEDING; CLINICAL TRIAL; DISEASE SEVERITY; DRUG EFFECT; HUMAN; INTENSIVE CARE; LETTER; META ANALYSIS; PH; PRIORITY JOURNAL; SEPSIS; STRESS ULCER; TREATMENT OUTCOME;

EID: 3142709964     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000130833.92258.B9     Document Type: Letter

References (5)

1. Dellinger RP, Carlet JM, Masur H, et al: Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 2004; 32:858-873
2. Cook DJ, Witt LG, Cook RJ, et al: Stress ulcer prophylaxis in the critically ill: A meta-analysis. Am J Med 1991; 91:519-527
3. Ben-Menachem T, Fogel R, Patel RV, et al: Prophylaxis for stress-related gastric hemorrhage in the medical intensive care unit. Ann Intern Med 1994; 568-575
4. Reusser P, Gyr K, Scheidegger D, et al: Prospective endoscopic study of stress erosions and ulcers in critically ill neurosurgical patients: Current incidence and effect of acid-reducing prophylaxis. Crit Care Med 1990; 18:270-274
5. Ruiz-Santana S, Ortiz E, Gonzalez B, et al: Stress-induced gastroduodenal lesions and total parenteral nutrition in critically ill patients: Frequency, complications, and the value of prophylactic treatment. A prospective, randomized study. Crit Care Med 1991; 19:887-891